SAN DIEGO-Tuesday, April 3rd 2018 [ AETOS Wire ]
(BUSINESS WIRE)
-- ResMed (NYSE: RMD, ASX: RMD) today announced the hire of its first
chief technology officer (CTO), Bobby Ghoshal, effective today.
As CTO,
Ghoshal will lead ResMed’s global healthcare informatics and data
analytics team to drive its world-leading cloud-based digital health
platforms as well as investments in emerging health technologies like
artificial intelligence and machine learning.
Ghoshal has
more than 25 years’ experience in information technology, semiconductor
innovation, digital strategy, information security, advanced analytics,
operations and customer care. Since 2016, Ghoshal has been chief
operating officer at Brightree, a ResMed-owned provider of cloud-based
software-as-a-service for out-of-hospital care. From 2012 to 2016, he
was vice president of information technology at ResMed. Previously,
Ghoshal worked in a number of management and technical roles in the
semiconductor and financial industries.
“Bobby has
played several key roles in ResMed’s emergence as a world-leading
connected health company this past decade, and we’re excited to appoint
him as our new CTO,” said ResMed CEO Mick Farrell. “I have worked with
Bobby for many years and he has incredible energy, integrity,
intelligence and an always-learning attitude that will guide ResMed’s
emerging competence in artificial intelligence, machine learning, deep
neural networks and other data analytics technologies to change the
lives of millions more patients.”
“I’m excited
to lead ResMed’s extraordinary healthcare informatics team to help drive
the value of connected health, leveraging the power of technology and
data for the hundreds of millions of people who suffer from sleep apnea,
COPD, and related chronic diseases worldwide,” said Ghoshal.
ResMed’s
Healthcare Informatics team had been led by Raj Sodhi, current president
of ResMed’s software-as-a-service businesses, pioneering
out-of-hospital software growth globally.
“I’m excited
for Bobby’s return to the ResMed team,” Sodhi said. “With Bobby as CTO, I
can be fully focused on expanding the capabilities of ResMed’s SaaS
solutions for out-of-hospital care, while Bobby leads the next level of
tech innovation, investments and partnerships that will take our digital
health capabilities to new frontiers, for the ultimate benefit of
patients, physicians, providers and payers.”
About ResMed
ResMed (NYSE:
RMD, ASX: RMD), a world-leading connected health company with more than
4 million cloud-connected devices for daily remote patient monitoring,
changes lives with every breath. Its award-winning devices and software
solutions help treat and manage sleep apnea, chronic obstructive
pulmonary disease and other respiratory conditions. Its 6,000-member
team strives to improve patients’ quality of life, reduce the impact of
chronic disease and save healthcare costs in more than 120 countries. ResMed.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180402005222/en/
Contacts
ResMed
For media:
Jayme Rubenstein, +1 858-836-6798
news@resmed.com
or
For investors:
David Pendarvis, +1 858-836-5983
investorrelations@resmed.com